Skip to main content
Sunshine Biopharma Inc. logo

Sunshine Biopharma Inc. — Investor Relations & Filings

Ticker · SBFM ISIN · US8677817004 LEI · 5299005Y64EHRQDQ2Q25 US Manufacturing
Open in API
Filings indexed 382 across all filing types
Latest filing 2022-05-20 Capital/Financing Update
Country US United States of America
Listing US SBFM

About Sunshine Biopharma Inc.

https://www.sunshinebiopharma.com/

Sunshine Biopharma Inc. is a pharmaceutical company engaged in the research, development, and commercialization of life-saving medicines. The company's primary focus is on various therapeutic areas, with a significant emphasis on oncology and antiviral treatments.

Recent filings

Filing Released Lang Actions
FORM 424B3
Capital/Financing Update Classification · 95% confidence The document is a Form 424B3 prospectus filed pursuant to Rule 424(b)(3) under the Securities Act of 1933. It details the resale registration of shares of common stock by selling stockholders, including shares issuable upon exercise of warrants from a private placement. The document includes information about the securities offered, risk factors, use of proceeds, plan of distribution, and legal matters. It is a registration prospectus related to a resale offering, not a financial report, earnings release, or management discussion. The primary purpose is to provide disclosure for the resale of securities by existing shareholders, which fits the category of Capital/Financing Update (CAP) as it relates to securities offerings and capital raising activities. The document is lengthy (15,000 characters) and contains substantive information about the offering, not just an announcement or certification, so it is not RPA or RNS. Therefore, the best classification is CAP with high confidence.
2022-05-20 English
Regulatory Filings 2022
Regulatory Filings Classification · 95% confidence The document is a letter from Sunshine Biopharma, Inc. to the SEC requesting acceleration of the effectiveness of a Registration Statement on Form S-3. It is a regulatory communication related to a securities registration process, not a financial report or detailed filing. The document length is short (880 characters), and it does not contain financial data or report content. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance communication.
2022-05-18 English
Regulatory Filings 2022
Regulatory Filings Classification · 90% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, or references to specific report types, fiscal periods, or regulatory bodies. There is no indication that this is a report itself or an announcement of a report. Due to the lack of identifiable information and the fallback rule for documents that do not fit any specific category, the appropriate classification is Regulatory Filings (RNS). The document length is 15,000 characters, which is substantial, but without meaningful content, it cannot be classified as a financial or other specific report type.
2022-05-18 English
FORM S-3
Capital/Financing Update Classification · 95% confidence The document is a Form S-3 Registration Statement filed with the SEC, which is used for registering securities for resale by selling stockholders. It includes detailed information about the securities being registered, the selling stockholders, and the terms of the offering. The document is not a financial report, earnings release, or management discussion, but rather a capital markets filing related to securities registration and resale. This fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes through the registration of shares for resale. The document length is substantial and contains detailed offering information, not just an announcement or notice, so it is not an RPA or RNS. Therefore, the appropriate classification is CAP with high confidence.
2022-05-10 English
FORM 10-Q
Interim / Quarterly Report Q1 2022
2022-05-06 English
Regulatory Filings 2022
Regulatory Filings
2022-04-29 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.